BMY
Bristol-Myers Squibb Co
Price:  
49.75 
USD
Volume:  
9,394,601.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy DCF Valuation - Growth Exit 5Y

-365.0%
Upside

What is the DCF valuation of Bmy??

The Discounted Cash Flow (DCF) valuation of Bristol-Myers Squibb Co (BMY) is (131.83) USD. With the latest stock price at 49.75 USD, the upside of Bristol-Myers Squibb Co based on DCF is -365.0%.

Is Bmy a buy or a sell?

Based on the latest price of 49.75 USD and our DCF valuation, Bristol-Myers Squibb Co (BMY) is a sell. selling Bmy stocks now will result in a potential gain of 365.0%.

Note: valuation result may not be accurate due to the low predictability of business.

Range Selected
WACC / Discount Rate 5.1% - 6.7% 5.9%
Long-term Growth Rate 3.0% - 4.8% 3.9%
Fair Price (879.93) - (81.54) (131.83)
Upside -1868.7% - -263.9% -365.0%
49.75 USD
Stock Price
(131.83) USD
Fair Price